Published: 12 June 2025

A new report, ‘Achieving inclusivity in clinical research’, has been jointly published today by the Association of Medical Research Charities (AMRC) and Association of the British Pharmaceutical Industry (ABPI).

The report summarises an event held by the two organisations in March, which brought together people from across the UK clinical research sector to explore inclusivity and representativeness in clinical research, and how to make sure that the development of innovative medicines meets the needs of the patients.

Read the report

The report includes three key actions to achieve meaningful improvements in diversity and inclusivity at all levels of clinical research:

• Develop a cross-sector, UK-wide strategy and roadmap for greater access to and inclusion in clinical trials.
• Share and promote best practice for improving clinical research inclusion.
• Develop an approach for measuring, collecting and reporting clinical trial diversity.

Nicola Perrin, Chief Executive of the Association of Medical Research Charities (AMRC) said: “The participation of diverse and under-served groups in research is essential to improving our understanding of how illnesses affect different people and ensure that new innovations work safely and effectively for everyone. Charities are doing fantastic things already, but as this report makes clear, collaborative and coordinated effort across the whole system is needed to drive lasting change.”

Dr Janet Valentine, Executive Director of Innovation and Research Policy at the ABPI said: “It is important that a representative population participates in clinical trials to ensure that the medicines produced work effectively across the patient group they are intended to treat.

“Prioritising diversity and inclusivity in clinical research strengthens the validity and generalisability of study findings, which means that more patients can benefit from the latest innovative medicines. We hope this report catalyses the necessary system changes that will support more eligible patients taking part in clinical research.”   

We’ve also published a blog, which provides further information about the event and the themes of the report.

Read the blog